Latest News Early Warning—How a Simple Blood Draw May Predict IPF Survival Posted on October 5, 2019 By Responsum for PF Researchers at Stanford University School of Medicine have shown that immune cells from a blood sample are linked to worse outcomes in IPF.... Read More
Latest News What Americans Should Know About Treatment with Esbriet® (Pirfenidone) for IPF Posted on September 18, 2019 By Responsum for PF Get the facts on one of two common IPF treatments with the Pulmonary Fibrosis Foundation’s new Fact Sheet Series.... Read More
Latest News Stopping and Reversing IPF—Promedior’s Push for a Cure Posted on August 18, 2019 By Responsum for PF In a recent podcast, Promedior CEO Jason Lettmann was interviewed about PRM-151, his company’s experimental drug treatment for IPF and other scarring diseases.... Read More